Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHOE
2326
Shoe Station Group
SHOE
$379M
| $7.85M | ﹤0.01% |
241,997
+159,847
| +195% | +$5.57M |
|
2327
Seanergy Maritime Holdings
SHIP
$387M
| $7.79M | ﹤0.01% |
537,546
+506,573
| +1,636% | +$5.92M |
|
2328
Coherus Oncology
CHRS
$219M
| $7.78M | ﹤0.01% |
484,025
+235,903
| +95% | +$3.46M |
|
2329
CALL
Truist Financial
TFC
$61.8B
| $7.78M | ﹤0.01% |
+132,600
| New | +$7.41M |
|
|
ETWO
2330
DELISTED
E2open Parent Holdings
ETWO
| $7.77M | ﹤0.01% |
687,889
-771,899
| -53% | -$8.67M |
|
|
VYGG
2331
DELISTED
Vy Global Growth
VYGG
| $7.77M | ﹤0.01% |
791,815
-558,887
| -41% | -$5.48M |
|
2332
PUT
DexCom
DXCM
$34B
| $7.76M | ﹤0.01% |
56,800
-277,200
| -83% | -$35M |
|
|
KCAC
2333
DELISTED
Kensington Capital Acquisition Corp. II
KCAC
| $7.75M | ﹤0.01% |
936,501
+271,274
| +41% | +$2.68M |
|
|
AIV
2334
Aimco
AIV
$372M
| $7.75M | ﹤0.01% |
1,131,047
-980,628
| -46% | -$6.75M |
|
2335
Albertsons Companies
ACI
$6.09B
| $7.74M | ﹤0.01% |
248,604
-578,900
| -70% | -$15.2M |
|
2336
Stantec
STN
$8.41B
| $7.73M | ﹤0.01% |
164,424
+138,200
| +527% | +$6.55M |
|
2337
Iron Mountain
IRM
$36B
| $7.73M | ﹤0.01% |
177,834
-169,402
| -49% | -$7.62M |
|
|
BWIN
2338
Baldwin Insurance Group
BWIN
$3B
| $7.73M | ﹤0.01% |
232,123
+58,414
| +34% | +$1.83M |
|
|
FSRD
2339
DELISTED
Fast Radius, Inc. Class A Common Stock
FSRD
| $7.71M | ﹤0.01% |
780,734
+225,763
| +41% | +$2.22M |
|
2340
Selective Insurance
SIGI
$5.54B
| $7.71M | ﹤0.01% |
102,076
+40,026
| +65% | +$3.22M |
|
2341
Oceaneering
OII
$5.01B
| $7.7M | ﹤0.01% |
+578,063
| New | +$7.54M |
|
2342
CALL
ResMed
RMD
$34.5B
| $7.7M | ﹤0.01% |
29,200
-10,800
| -27% | -$2.95M |
|
|
FRGE
2343
DELISTED
Forge Global Holdings
FRGE
| $7.69M | ﹤0.01% |
51,811
+12,403
| +31% | +$1.82M |
|
|
SDC
2344
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $7.69M | ﹤0.01% |
1,445,460
+576,143
| +66% | +$3.58M |
|
2345
Brady Corp
BRC
$4.38B
| $7.69M | ﹤0.01% |
151,609
+111,730
| +280% | +$5.89M |
|
2346
ePlus
PLUS
$2.28B
| $7.68M | ﹤0.01% |
149,776
+87,630
| +141% | +$4.33M |
|
|
SAFE
2347
DELISTED
Safehold Inc.
SAFE
| $7.66M | ﹤0.01% |
106,608
+76,133
| +250% | +$6.46M |
|
2348
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.6B
| $7.66M | ﹤0.01% |
87,586
-77,816
| -47% | -$6.83M |
|
2349
CALL
Globus Medical
GMED
$11B
| $7.66M | ﹤0.01% |
100,000
+50,000
| +100% | +$4.01M |
|
2350
CALL
International Flavors & Fragrances
IFF
$22.4B
| $7.65M | ﹤0.01% |
57,200
+11,000
| +24% | +$1.62M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.